Can income-based co-payment rates improve disparity? The case of the choice between brand-name and generic drugs

Overview of attention for article published in BMC Health Services Research, November 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Average Attention Score compared to outputs of the same age and source

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 7,449 followers.

RT @UCDavis_HPM: Professor Yoo and colleages find that co-payment rates appeared to reduce disparity in access to brand-name drugs across i…

RT @UCDavis_HPM: Professor Yoo and colleages find that co-payment rates appeared to reduce disparity in access to brand-name drugs across i…

Professor Yoo and colleages find that co-payment rates appeared to reduce disparity in access to brand-name drugs across income groups. Read more at https://t.co/P1SYSIXlQI @UCDavis_HPM @UCDavis_PHS @UCDavisHealth @ucdavis @UCDavisResearch @UCDavisMagazi

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.